Sinopharm Group Co. Ltd. total revenue, net income and dynamics of changes in Euro today
The dynamics of Sinopharm Group Co. Ltd. net revenue grew by 4 959 539 282 € compared to the previous report. Sinopharm Group Co. Ltd. net income is now 2 228 801 484 €. These are the main financial indicators of Sinopharm Group Co. Ltd.. Graph of the financial report of Sinopharm Group Co. Ltd.. The financial report chart on our website displays information by dates from 30/09/2018 to 31/12/2020. Sinopharm Group Co. Ltd. financial report on the graph shows the dynamics of assets.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2020
118 313 961 181.12 €
-
2 047 272 289.53 €
-
30/09/2020
113 758 361 495.02 €
+11.55 % ↑
1 894 786 091.06 €
+27.33 % ↑
30/06/2020
93 584 343 750.87 €
-4.324 % ↓
1 329 918 694.07 €
-20.892 % ↓
31/03/2020
93 584 343 750.87 €
+7.04 % ↑
1 329 918 694.07 €
+26.45 % ↑
30/09/2019
101 980 514 538.65 €
-
1 488 115 797.42 €
-
30/06/2019
97 813 486 937.76 €
-
1 681 134 404.52 €
-
31/03/2019
87 426 633 323.21 €
-
1 051 724 272.91 €
-
30/09/2018
80 232 613 143.45 €
-
1 211 801 371.34 €
-
Show:
to
Sinopharm Group Co. Ltd. financial report charts
Dates of Sinopharm Group Co. Ltd. finance reports: 30/09/2018, 30/09/2020, 31/12/2020. The dates of the financial statements are determined by the accounting rules. The current date of the financial report of Sinopharm Group Co. Ltd. for today is 31/12/2020. Gross profit Sinopharm Group Co. Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Sinopharm Group Co. Ltd. is 11 563 534 265 €
Sinopharm Group Co. Ltd. quarterly report dates
Cost of revenue Sinopharm Group Co. Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Sinopharm Group Co. Ltd. is 117 241 184 876 € Total revenue Sinopharm Group Co. Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Sinopharm Group Co. Ltd. is 128 804 719 141 € Operating income Sinopharm Group Co. Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Sinopharm Group Co. Ltd. is 6 111 739 655 €
Net income Sinopharm Group Co. Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Sinopharm Group Co. Ltd. is 2 228 801 484 € Current assets Sinopharm Group Co. Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Sinopharm Group Co. Ltd. is 267 609 973 000 € Total assets Sinopharm Group Co. Ltd. refers to the total amount of assets owned by a person or entity. Total assets Sinopharm Group Co. Ltd. is 311 236 706 000 €
31/12/2020
30/09/2020
30/06/2020
31/03/2020
30/09/2019
30/06/2019
31/03/2019
30/09/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
10 621 719 089.72 €
10 579 803 192.39 €
7 918 788 003.44 €
7 918 788 003.44 €
8 946 077 152.65 €
9 002 254 056.52 €
7 058 634 125.84 €
7 454 801 689.98 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
107 692 242 091.40 €
103 178 558 302.64 €
85 665 555 747.43 €
85 665 555 747.43 €
93 034 437 386 €
88 811 232 881.24 €
80 367 999 197.37 €
72 777 811 453.47 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
118 313 961 181.12 €
113 758 361 495.02 €
93 584 343 750.87 €
93 584 343 750.87 €
101 980 514 538.65 €
97 813 486 937.76 €
87 426 633 323.21 €
80 232 613 143.45 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
5 613 956 795.32 €
4 969 098 318.11 €
3 481 613 940.45 €
3 481 613 940.45 €
4 021 322 975.41 €
4 731 408 245.61 €
2 905 806 980.48 €
3 291 527 548.34 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
2 047 272 289.53 €
1 894 786 091.06 €
1 329 918 694.07 €
1 329 918 694.07 €
1 488 115 797.42 €
1 681 134 404.52 €
1 051 724 272.91 €
1 211 801 371.34 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-89 323 130.46 €
89 323 130.46 €
89 323 130.46 €
89 323 130.46 €
88 901 227.12 €
-30 163 516.90 €
30 163 516.90 €
68 574 148.01 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
112 700 004 385.80 €
108 789 263 176.92 €
90 102 729 810.42 €
90 102 729 810.42 €
97 959 191 563.23 €
93 082 078 692.15 €
84 520 826 342.73 €
76 941 085 595.12 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
245 813 943 529.07 €
257 811 856 547.91 €
243 338 037 193.64 €
243 338 037 193.64 €
228 652 922 803.44 €
217 980 674 342.83 €
205 848 915 404.22 €
-
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
285 887 410 006.42 €
297 794 784 721.75 €
281 381 265 472.87 €
281 381 265 472.87 €
263 632 245 597.24 €
252 129 295 770.90 €
235 053 900 196.17 €
-
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
46 091 395 850.55 €
36 236 304 769.76 €
36 120 595 809.40 €
36 120 595 809.40 €
32 260 582 447.74 €
30 724 672 867.13 €
30 882 935 220.81 €
-
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
182 158 972 318.65 €
176 045 462 599.81 €
163 087 604 415.01 €
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
195 712 999 671.68 €
186 287 964 188.49 €
170 229 235 002.49 €
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
74.24 %
73.89 %
72.42 %
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
51 768 586 151.29 €
49 798 821 439.21 €
47 736 899 961.72 €
47 736 899 961.72 €
42 161 797 386.04 €
40 577 769 526.86 €
40 494 676 139.50 €
-
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-2 041 835 007.82 €
7 653 992 971.41 €
-19 909 339 957.15 €
-2 381 415 210.85 €
Last revenue report of Sinopharm Group Co. Ltd. was 31/12/2020. According to last financial report total revenue in Sinopharm Group Co. Ltd. was 118 313 961 181.12 Euro and changed by +11.55% since last year. Net income in Sinopharm Group Co. Ltd. was 2 047 272 289.53 € in last quartal, net income changes to +27.33%.
Current cash Sinopharm Group Co. Ltd. - the sum of all of the cash a company has on the date of report. Current cash Sinopharm Group Co. Ltd. is 50 178 265 000 €
Sinopharm Group Co. Ltd. stocks data
X2S.F stock price
Sinopharm Group Co. Ltd. stock price today, X2S.F stock quote.
